Immunotherapy based on bispecific T‐cell engager with hIgG 1 Fc sequence as a new therapeutic strategy in multiple myeloma
Author:
Affiliation:
1. The Cyrus Tang Hematology Center Soochow University SuzhouChina
2. Collaborative Innovation Center of Hematology Soochow University SuzhouChina
3. Suzhou Cancer Immunotherapy and Diagnosis Engineering Center Suzhou China
Funder
National Natural Science Foundation of China
Science and Technology Support Program Project of Jiangsu Province, China
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12631
Reference22 articles.
1. Multiple myeloma
2. Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia
3. Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
4. Pegylated Liposomal Doxorubicin
5. Review of therapy for relapsed/refractory multiple myeloma
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bispecific antibodies in the treatment of multiple myeloma;Blood Cancer Journal;2024-09-12
2. Bispecific Antibodies for Multiple Myeloma: Recent Advancements and Strategies for Increasing Their Efficacy;Frontiers in Bioscience-Landmark;2024-06-17
3. Targeted therapy for multiple myeloma: an overview on CD138-based strategies;Frontiers in Oncology;2024-04-09
4. Genetic code expansion in E. coli enables production of a functional ‘ready-to-click’ T cell receptor-specific scFv;New Biotechnology;2023-09
5. The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review;Antibodies;2023-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3